Home
Live Updates
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2023 Earnings Call Transcript : comparemela.com
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2023 Earnings Conference Call. Today's call is being recorded.
Related Keywords
United States ,
American ,
Anjali Ganguli ,
Eva Privitera ,
Kalpit Patel ,
Brad Canino ,
Neil Gallagher ,
Sharon Klahre ,
Anupam Rama ,
Madhu Kumar ,
Michael Metzger ,
Peter Lawson ,
Dara Azar ,
Incyte Jakafi ,
Keith Goldan ,
Sanofi Rezurock ,
Yigal Nochomovitz ,
Peter Ordentlich ,
Kevin Mcmanus ,
Justin Zelin ,
Joel Beatty ,
Syndax Pharmaceuticals Inc ,
Lymphoma Society ,
American Thoracic Society Conference On ,
Barclays ,
Nasdaq ,
Lymphoma Group ,
Goldman Sachs ,
Citigroup ,
Head Of Investor Relations At Syndax Pharmaceuticals ,
Syndax Pharmaceuticals ,
Call Transcript May ,
Syndax First Quarter ,
Investor Relations ,
Chief Executive Officer ,
Chief Financial ,
Chief Scientific Officer ,
Chief Business ,
Private Securities Litigation Reform Act ,
Risk Factors ,
Chief People ,
Breakthrough Therapy ,
Master Clinical Trial ,
Australasian Leukaemia ,
Clinical Oncology ,
Lee Symptom ,
American Thoracic Society Conference ,
Maybei Ll ,
Real Time Oncology Review ,
American Thoracic Society Annual Meeting ,
European Hematology Association Annual Meeting ,
Goldman Sachs Healthcare Conference ,
comparemela.com © 2020. All Rights Reserved.